Loading...
Symbols:
Loading...
Symbols:
Roche Holdings AG Basel (RHHBY.PK)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Roche Holdings AG Basel (RHHBY.PK)
99 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on RHHBY.PK
- Centient Biotech Investor(18)
- Mike Huckman(12)
- Mike Havrilla(7)
- Derek Lowe(7)
- ChinaBio Today(7)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(572)
- SA Editor Eli Hoffmann(386)
- SA Editor Judy Weil(185)
- SA Editor Rachael Granby(176)
- Stockerblog (168)
Most commented on authors
- SA Editor Eli Hoffmann(41)
- Derek Lowe(13)
- Mike Huckman(12)
- SA Editor Rachael Granby(9)
- Zacks.com (9)
- Nine Pharma Predictions for 2009
- Roche Says It'll Still Buy Genentech, Investors Think Otherwise
- Regenerative Medicine: Big Pharma's Next Frontier
- Market Update: Roche/Genentech Deal, AstraZeneca's New Statin, Yahoo, Microsoft Deal?
- China Bio in Review: More Fallout from Economic Crisis
- Boning Up on Amgen's D-mab for Osteoporosis
- Roche Intent on Discovering Innovative Medicines in China
- Consumer Staples, Healthcare Lift Swiss ETF Above Peers
- Expanding the Defensive Growth Index Into Europe
- Roche: Why No News About Genentech from Earnings Call?
- A Defensive Growth Stock Index
- Ten Highest Yielding Pharma Stocks
- Even Fatter Yields for Pfizer; M&A Targets in the Sector
- Genentech on Roche's Plans: Our Lips Are Sealed
- Wall Street Breakfast: Must-Know News
- U.K. Limits 'Quality of Life' Meds to £30,000 a Year
- Some Good News in Biotech
- Discovery Labs: The Next Biotech Buy?
- Wall Street Breakfast: Must-Know News
- Roche Covets Genentech for Good Reason
- Yangtze River Delta Developing Huge R&D Base for Drug Companies
- China Bio Week-in-Review: Trials and Deals
- Roche Chemo Drug Approved in China for Gastric Cancer
- Biotech Outlook: M&A Will Continue
- China's Hepatitis B Market to Double by 2012
- Largest Companies in the World
- The Genentech Guessing Game - What Will Roche Offer Next?
- Tough Projections for Big Pharmas: Drug Revenues Don't Look Promising
- Would Genentech Be Better Off Left Alone by Roche?
- 5 Potential Buyout Targets in Biotech - Barron's
- Genentech Pipeline: Too Good To Settle for Less?
- Global Investing Roundup: 8/14/08
- Updates on the Healthcare/Biotech Mergers
- Big Pharma’s Healthy Appetite for Acquisitions
- By How Much Will Roche Increase Its Valuation for Genentech?
- What's Going On at Roche Palo Alto?
- What Price Might Roche Pay for DNA?
- Watch for More Coming Biotech Acquisitions
- Novartis: An Ex-U.S. Proxy for Global Healthcare
- Should Genentech Become Part of Roche?
- ARIUS Research: Stock Up on Roche Takeover Bid
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
2 new today)